Gingival recession is a common deformity, and tissue engineering, using active regeneration, is emerging as a modern approach for management. This study aimed to evaluate the efficacy of autologous gingival fibroblasts seeded onto a volume-stable collagen matrix (VSCM) in treating gingival recession. A split-mouth randomized controlled clinical trial was conducted on 20 sites in 10 patients presenting with Miller Class I and II gingival recession. Sites were allocated to receive either coronally advanced flap (CAF) with volume-stable collagen matrix (VSCM) (control) or CAF with fibroblast-seeded volume-stable collagen matrix (FVSCM) (test). Autologous gingival fibroblasts were cultured and seeded onto VSCM before transplantation. Plaque index (PI), probing depth (PD), clinical attachment level (CAL), recession depth (RD), recession width (RW), and keratinized tissue width (KTW) were recorded at baseline, 1, 3, and 6 months. Secondary outcomes included Early Healing Score (EHS), Root Coverage Esthetic Score (RCES), and Visual Analog Scale (VAS). Statistical analysis was performed using SPSS (V23) and p < 0.05 was considered significant. Both groups demonstrated significant improvements in clinical parameters over time. The test group showed significantly greater CAL gain and reduction in RD and RW at all follow-up intervals, with sustained outcomes at 6 months. PI and PD remained comparable between groups. Although EHS, RCES, and KTW showed favourable trends in the test group, differences were not statistically significant. Autologous fibroblast-seeded collagen membranes show promise as a biologically driven alternative for managing gingival recession. Further multicentric trials are warranted for long-term validation.
11 July 2025 in Odovtos - International Journal of Dental Sciences
Periodontal disease is a chronic inflammatory condition marked by the destruction of the supporting apparatus of the tooth. The pathogenesis is largely determined by an imbalance between the pro-inflammatory and anti-inflammatory mediators. IL-23, being pro-inflammatory in nature, contributes to tissue inflammation and deregulation through the production of IL-17. On the other hand, IL-27 exerts an anti-inflammatory effect by regulating the immune response by inhibiting IL-17. The current study aimed to assess IL-23 and IL-27 levels in gingival crevicular fluid (GCF) and saliva in periodontal health and disease. Forty systemically healthy subjects were allocated into three groups: healthy (Group A, n=10), gingivitis (Group B, n=15), and periodontitis (Group C, n=15). Clinical parameters including probing depth (PD) and clinical attachment loss (CAL) were recorded. GCF and saliva samples were collected to quantify IL-23 and IL-27 levels which were analyzed using a multiplex ELISA (ProcartaPlex™ Human Th9/Th17/Th22 Cytokine Panel). The results were statistically analysed using SPSS software (version 21.0, IBM, USA). IL-23 levels in both GCF and saliva significantly increased from healthy to gingivitis to periodontitis (p < 0.05). Conversely, IL-27 levels decreased progressively across the same groups (p < 0.05). IL-23 levels showed a strong positive correlation with PD and CAL, while IL-27 levels were negatively correlated with these parameters, particularly in the periodontitis group. Elevated IL-23 levels are associated with greater disease severity, whereas IL-27 appears to exert a protective, anti-inflammatory effect. The study highlights the potential of both cytokines as biomarkers for diagnosing and monitoring periodontal conditions. However, to confirm their clinical relevance, further longitudinal studies with larger cohorts are recommended.